Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $116
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $119 to $116.
Masimo’s (MASI) Q2 Earnings Surpass Estimates, Margins Down
Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.
NeuroOne Medical Shares Fall After EEG Electrode Regulatory Update
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) has submitted a special 510(k) to the FDA for its sEEG electrode to extend the duration…
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
Zimmer Biomet Holdings Inc’s (NYSE:ZBH) Q2 sales increased by 1% Y/Y to $1.78 billion (up 6% on a constant currency basis),…
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Stifel Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $120
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $140 to $120.
What 4 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter:
Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $115
Morgan Stanley analyst Cecilia Furlong maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and lowers the price target from $132 to $115.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 326 stocks hit new 52-week lows.